Diabetes News and Research

Latest Diabetes News and Research

Bayer HealthCare, Onyx to present data on Nexavar tablets at ESMO Congress

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that more than 20 studies evaluating the use of Nexavar® (sorafenib) tablets will be presented at the 35th European Society for Medical Oncology (ESMO) Congress, October 8-12, 2010 in Milan, Italy.

7 Oct 2010

First Edition: October 7, 2010

Today's headlines include stories on waivers given some companies that offer only minimal health insurance coverage, insurers' political efforts during this campaign season and efforts in New York to bar the use of food stamps to buy soda.

7 Oct 2010

Study finds link between language barriers and diabetes-related health outcomes

Patients who cannot discuss their diabetes with a doctor in their own language may have poorer health outcomes, even when interpreter services are available, according to a new study by researchers at UCSF and the Kaiser Permanente Division of Research.

7 Oct 2010

CCAW program launched at Baltimore County Department of Aging Senior Expo

In a unique partnership with sanofi-aventis U.S., the Baltimore County Department of Aging, and the John A. Hartford Foundation, the National Council on Aging is launching a pilot program to help physicians connect older patients with diabetes to evidence-based education and wellness support, right in their local community.

7 Oct 2010

Surgeons create novel matrix to control insulin dependent diabetes

Surgeons from Massachusetts General Hospital, Boston, are reporting on a whole new strategy for controlling insulin dependent diabetes without daily injections of insulin. The surgeons have bio-engineered a novel matrix that serves as a scaffold for seeding supportive stem cells as well as pancreatic islets (the cells that produce insulin in the pancreas).

7 Oct 2010

Endocrine Society urges physicians to apply new insights into the role of beta-cells in type 2 diabetes

A new consensus statement published in the September, 2010, issue of The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) finds that the increasing recognition that beta-cell failure occurs much earlier and severely than commonly believed suggests that regular glycemia screening, early identification of patients at metabolic risk and prompt and aggressive intervention deserves greater emphasis.

7 Oct 2010

Gymnemic acid nanocrystals could help develop soluble drug compounds

Researchers in India have demonstrated that producing nanoscopic crystals of a pharmaceutical product can allow the medication to be absorbed by the gut even if the drug is not soluble in water.

7 Oct 2010

Cincinnati Children's Hospital receives $12 million grant to create IBD registry

Building on the success of previous efforts among researchers and caregivers to improve the care of chronically ill children, a $12-million grant to Cincinnati Children's Hospital Medical Center will allow creation of a registry system unlike any before it, providing information in real time on thousands of cases around the country – and eventually the world.

7 Oct 2010

Waist size can predict diabetes risk

A higher rate of diabetes seen among adult Americans when compared to peers in England is explained primarily by a larger waist size rather than conventional risk factors such as obesity, according to a new study by researchers from the RAND Corporation, University College London and the Institute for Fiscal Studies in London.

7 Oct 2010

'The Pittsburgh Protocol' enables reduction of multiple anti-rejection drugs after transplantation

The Pittsburgh Protocol is unique in utilizing bone marrow cells to enable reduction of the need for multiple anti-rejection drugs after transplantation. The University of Pittsburgh Medical Center is currently the only transplantation center in the world to offer it. An early report of the initial experience with the "Pittsburgh Protocol" in three recipients of upper extremity transplants was presented during the 2010 Annual Clinical Congress of the American College of Surgeons.

7 Oct 2010

ACEA, Vivo Biosciences collaborate to develop cell-based assays for xCELLigence System

ACEA Biosciences Inc. and Vivo Biosciences Inc. announced that they have entered into a collaboration for the further development of label-free and real-time cell based assays for the xCELLigence System, which is co-developed by Roche and ACEA and marketed by Roche Applied Science.

6 Oct 2010

Wound Care Innovations adds first pharmacy client to growing list of customers

Wound Management Technologies, Inc. announced today that its subsidiary Wound Care Innovations, LLC has added the company's first pharmacy client to its rapidly growing list of customers. Lewis Hall, Inc. of Fort Worth, TX is an independent pharmacy group that has several locations and 30 years experience in wound care, long term care and specialty compounded products for dermatologic use.

6 Oct 2010

Researchers discover mechanism of body fat accumulation

Using ice cream, candy bars and energy drinks to help volunteers gain weight, Mayo Clinic researchers have discovered the mechanisms of how body fat grows. Increased abdominal fat seems to heighten risk for metabolic disease, while fat expansion in the lower body as in the thighs seems to lower the risk. The findings, appearing in today's Proceedings of the National Academy of Sciences (PNAS), help explain why.

6 Oct 2010

MEPs organizes joint meeting to improve policies for tackling chronic diseases

In an unprecedented effort to bring prevention of chronic diseases to the top of the EU agenda, the MEP Heart Group , the MEP Group for Kidney Health , the EU Diabetes Working Group and MEPs Against Cancer organise a joint meeting today in the European Parliament, together with representatives of health professionals and health activists at European level.

6 Oct 2010

AOA launches 'Break Through Your Pain' public education campaign

If you're living in pain, you're certainly not alone. According to a new survey released today by the American Osteopathic Association (AOA) nearly 70% of Americans report that they, or someone they care for, have experienced pain during the past 30 days. While Congress declared 2000 to 2010 the "Decade of Pain Control and Research," chronic, or reoccurring pain still affects more Americans than cancer, diabetes and heart disease combined. In fact, more than 76 million people live in pain every day.

6 Oct 2010

Podocytes key to development of kidney failure in diabetes

Diabetes is the leading reason for kidney failure in the world, resulting in patients requiring dialysis or kidney transplantation. New research has found a cell in the kidney called the podocyte could be the key to understanding why this happens.

6 Oct 2010

Study on resistance of harmful bacteria to antibiotics

A study by two Florida State University biochemists makes an important contribution to science's understanding of a serious problem causing concern worldwide: the growing resistance of some harmful bacteria to the drugs that were intended to kill them.

6 Oct 2010

SJMHS and IHA announce strategic merger to develop new integrated health network

Saint Joseph Mercy Health System (SJMHS) and IHA, the region's leading physician group practice, both of Ann Arbor, Mich., today announced a strategic merger with the goal of developing a new integrated health network. The merger is expected to be effective on or before December 31, at which time IHA will be a member of SJMHS and will initially serve as the integrated physician enterprise for these St. Joseph Mercy Hospital markets: Washtenaw, Livingston and portions of western Wayne and south western Oakland counties.

6 Oct 2010

Insulin-sensitizing drugs may offer new treatments for kidney failure

Evidence reported in the October issue of Cell Metabolism, a Cell Press publication, offers a completely new explanation for why people with diabetes account for more than half of all patients requiring dialysis or kidney transplantation. It appears that insulin has a significant influence on the structure and proper function of a particular group of very specialized cells, known as podocytes, that are integral to the kidney's ability to do its job filtering blood.

6 Oct 2010

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.

6 Oct 2010

Diabetes News and Research

Latest Diabetes News and Research

Bayer HealthCare, Onyx to present data on Nexavar tablets at ESMO Congress

First Edition: October 7, 2010

Study finds link between language barriers and diabetes-related health outcomes

CCAW program launched at Baltimore County Department of Aging Senior Expo

Surgeons create novel matrix to control insulin dependent diabetes

Endocrine Society urges physicians to apply new insights into the role of beta-cells in type 2 diabetes

Gymnemic acid nanocrystals could help develop soluble drug compounds

Cincinnati Children's Hospital receives $12 million grant to create IBD registry

Waist size can predict diabetes risk

'The Pittsburgh Protocol' enables reduction of multiple anti-rejection drugs after transplantation

ACEA, Vivo Biosciences collaborate to develop cell-based assays for xCELLigence System

Wound Care Innovations adds first pharmacy client to growing list of customers

Researchers discover mechanism of body fat accumulation

MEPs organizes joint meeting to improve policies for tackling chronic diseases

AOA launches 'Break Through Your Pain' public education campaign

Podocytes key to development of kidney failure in diabetes

Study on resistance of harmful bacteria to antibiotics

SJMHS and IHA announce strategic merger to develop new integrated health network

Insulin-sensitizing drugs may offer new treatments for kidney failure

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

Industry Focus eBook - Medical device (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in